Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors.
Mönch S, Heimer MM, Winkelmann M, Guertler A, Schlaak M, Tufman A, Ben Khaled N, de Toni E, Westphalen CB, von Bergwelt-Baildon M, Dinkel J, Kazmierczak PM, Ingrisch M, Mansour N, Unterrainer M, Heinzerling L, Ricke J, Kunz WG. Mönch S, et al. Among authors: winkelmann m. Cancer Imaging. 2023 Jun 8;23(1):58. doi: 10.1186/s40644-023-00580-9. Cancer Imaging. 2023. PMID: 37291665 Free PMC article.
The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18).
Weckbach LT, Gola A, Winkelmann M, Jakob SM, Groesser L, Borgolte J, Pogoda F, Pick R, Pruenster M, Müller-Höcker J, Deindl E, Sperandio M, Walzog B. Weckbach LT, et al. Among authors: winkelmann m. Blood. 2014 Mar 20;123(12):1887-96. doi: 10.1182/blood-2013-06-510875. Epub 2014 Jan 23. Blood. 2014. PMID: 24458438 Free article.
Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies.
Dos Santos DMC, Rejeski K, Winkelmann M, Liu L, Trinkner P, Günther S, Bücklein VL, Blumenberg V, Schmidt C, Kunz WG, Von Bergwelt-Baildon M, Theurich S, Subklewe M. Dos Santos DMC, et al. Among authors: winkelmann m. Haematologica. 2022 Sep 1;107(9):2096-2107. doi: 10.3324/haematol.2021.280189. Haematologica. 2022. PMID: 35172565 Free PMC article.
Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells.
Karschnia P, Rejeski K, Winkelmann M, Schöberl F, Bücklein VL, Blumenberg V, Schmidt C, Blobner J, von Bergwelt-Baildon M, Tonn JC, Kunz WG, Subklewe M, von Baumgarten L. Karschnia P, et al. Among authors: winkelmann m. Neurology. 2022 May 24;98(21):884-889. doi: 10.1212/WNL.0000000000200608. Epub 2022 Mar 29. Neurology. 2022. PMID: 35351785 Free PMC article.
Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival.
Winkelmann M, Rejeski K, Blumenberg V, Bücklein VL, Ruzicka M, Unterrainer M, Schmidt C, Dekorsy FJ, Bartenstein P, Ricke J, von Bergwelt-Baildon M, Subklewe M, Kunz WG. Winkelmann M, et al. Hemasphere. 2022 Sep 27;6(10):e781. doi: 10.1097/HS9.0000000000000781. eCollection 2022 Oct. Hemasphere. 2022. PMID: 36187874 Free PMC article. No abstract available.
175 results